Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases.The Canadian journal of cardiology · 2008
   Pooled it
2. Medicina (Kaunas, Lithuania) · 2026
   Article
3. Discovery of Human-Specific ImmunodominantmSphere · 2018
   Article
4. Association of Chlamydia pneumoniae Infection With Atherosclerotic Plaque Formation.Global journal of health science · 2015
   Article
5. Infection of human monocytes by Chlamydia pneumoniae and Chlamydia trachomatis: an in vitro comparative study.BMC research notes · 2014
   Article
6. Chlamydophila pneumoniae infection and cardiovascular disease.North American journal of medical sciences · 2013
   Article
7. Chronic infections & coronary artery disease with special reference to Chalmydia pneumoniae.The Indian journal of medical research · 2012
   Article
8. Assessment of some inflammatory biomarkers as predictors of outcome of acute respiratory failure on top of chronic obstructive pulmonary disease and evaluation of the role of bacteria.ISRN microbiology · 2012
   Article
9. Chlamydia in canine or feline coronary arteriosclerotic lesions.BMC research notes · 2011
   Article
10. Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patients.Cell stress & chaperones · 2011
    Article
11. Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?Medical microbiology and immunology · 2010
    Review
12. Antibiotic resistance in Chlamydiae.Future microbiology · 2010
    Review
13. Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns.Clinical and vaccine immunology : CVI · 2010
    Article
14. Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.Interdisciplinary perspectives on infectious diseases · 2010
    Article
15. Atherosclerosis, inflammation and Chlamydia pneumoniae.World journal of cardiology · 2009
    Article
16. Host cell cytokines induced by Chlamydia pneumoniae decrease the expression of interstitial collagens and fibronectin in fibroblasts.Infection and immunity · 2009
    Article
17. Chlamydophila pneumoniae derived from inclusions late in the infectious cycle induce aponecrosis in human aortic endothelial cells.BMC microbiology · 2008
    Article
18. Chlamydialike organisms and atherosclerosis.Emerging infectious diseases · 2006
    Article
19. In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results?Journal of clinical microbiology · 2005
    Review
20. Current status of stroke in Qatar: Including data from the BRAINS study.JRSM cardiovascular disease
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as